Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Secchi

Showing results (81-90 of 120) with videos related to

Pageof 12
Sort By:
Diabetes|September 8, 2011
Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetesAlessandra Ferraro, Carlo Socci, Angela Stabilini, et al.
Radiology|December 14, 2004
Technique, complications, and therapeutic efficacy of percutaneous transplantation of human pancreatic islet cells in type 1 diabetes: the role of USMassimo Venturini, Enzo Angeli, Paola Maffi, et al.
Diabetes Care|December 23, 2011
Near normalization of metabolic and functional features of the central nervous system in type 1 diabetic patients with end-stage renal disease after kidney-pancreas transplantationPaolo Fiorina, Paolo Vezzulli, Roberto Bassi, et al.
Diabetes|November 15, 2011
Inotuzumab ozogamicin murine analog-mediated B-cell depletion reduces anti-islet allo- and autoimmune responsesMichele Carvello, Alessandra Petrelli, Andrea Vergani, et al.
Transplantation|October 7, 2014
Calcineurin inhibitor-free immunosuppressive regimen in type 1 diabetes patients receiving islet transplantation: single-group phase 1/2 trialPaola Maffi, Thierry Berney, Rita Nano, et al.
The Journal of Clinical Investigation|September 22, 2012
CXCR1/2 inhibition enhances pancreatic islet survival after transplantationAntonio Citro, Elisa Cantarelli, Paola Maffi, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 17, 2005
Morphological and functional differences in haemostatic axis between kidney transplanted and end-stage renal disease patientsPaolo Fiorina, Franco Folli, Elisabetta Ferrero, et al.
The Lancet. Diabetes & Endocrinology|February 10, 2025
Long-term outcomes of pancreatic islet transplantation alone in type 1 diabetes: a 20-year single-centre study in ItalyDavide Catarinella, Raffaella Melzi, Alessia Mercalli, et al.
Diabetes|August 28, 2004
Normalization of multiple hemostatic abnormalities in uremic type 1 diabetic patients after kidney-pancreas transplantationPaolo Fiorina, Franco Folli, Armando D'Angelo, et al.
Diabetes|January 5, 2002
Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantationLorenzo Piemonti, Biagio Eugenio Leone, Rita Nano, et al.
Pageof 12

Showing results (81-90 of 120) with videos related to

Sort By:
Pageof 12
Diabetes|September 8, 2011
Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetesAlessandra Ferraro, Carlo Socci, Angela Stabilini, et al.
Radiology|December 14, 2004
Technique, complications, and therapeutic efficacy of percutaneous transplantation of human pancreatic islet cells in type 1 diabetes: the role of USMassimo Venturini, Enzo Angeli, Paola Maffi, et al.
Diabetes Care|December 23, 2011
Near normalization of metabolic and functional features of the central nervous system in type 1 diabetic patients with end-stage renal disease after kidney-pancreas transplantationPaolo Fiorina, Paolo Vezzulli, Roberto Bassi, et al.
Diabetes|November 15, 2011
Inotuzumab ozogamicin murine analog-mediated B-cell depletion reduces anti-islet allo- and autoimmune responsesMichele Carvello, Alessandra Petrelli, Andrea Vergani, et al.
Transplantation|October 7, 2014
Calcineurin inhibitor-free immunosuppressive regimen in type 1 diabetes patients receiving islet transplantation: single-group phase 1/2 trialPaola Maffi, Thierry Berney, Rita Nano, et al.
The Journal of Clinical Investigation|September 22, 2012
CXCR1/2 inhibition enhances pancreatic islet survival after transplantationAntonio Citro, Elisa Cantarelli, Paola Maffi, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 17, 2005
Morphological and functional differences in haemostatic axis between kidney transplanted and end-stage renal disease patientsPaolo Fiorina, Franco Folli, Elisabetta Ferrero, et al.
The Lancet. Diabetes & Endocrinology|February 10, 2025
Long-term outcomes of pancreatic islet transplantation alone in type 1 diabetes: a 20-year single-centre study in ItalyDavide Catarinella, Raffaella Melzi, Alessia Mercalli, et al.
Diabetes|August 28, 2004
Normalization of multiple hemostatic abnormalities in uremic type 1 diabetic patients after kidney-pancreas transplantationPaolo Fiorina, Franco Folli, Armando D'Angelo, et al.
Diabetes|January 5, 2002
Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantationLorenzo Piemonti, Biagio Eugenio Leone, Rita Nano, et al.
Pageof 12